Dr. Stovsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3615 Superior Avenue
Cleveland, OH 44114Phone+1 216-432-2700
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 1991 - 1997
- Northwestern University The Feinberg School of MedicineClass of 1991
- University of PittsburghMBA, 1988 - 1989
- Northwestern UniversityBA, Sociology, 1982 - 1986
Certifications & Licensure
- OH State Medical License 1996 - 2026
- American Board of Urology Urology
Awards, Honors, & Recognition
- Top Doctor Castle Connolly
- Best Doctors in America
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsIsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.Jason M Scovell, Mark Stovsky, Alan Partin, Yair Lotan, Jack Baniel
Urology. 2023-05-01 - 2 citationsElevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature.Tarik Benidir, Martin Hofmann, Zaeem Lone, Jane K Nguyen, Andrei S Purysko
Urology. 2022-10-01 - 7 citationsClinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study.Eric A Klein, Alan Partin, Yair Lotan, Jack Baniel, Martin Dineen
Urologic Oncology. 2022-09-01
Journal Articles
- IsoPSATM Improves Detection of Clinically Important CancersStovsky, M., Urology and Nephrology, 1/1/2016
- Next Generation Prostate Cancer Biomarker Shows PromiseUrology and Nephrology, 1/1/2015
- From Inspiration to Commercialization: How a Prostate Cancer Test Gets to MarketUrology and Nephrology, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The PSA debate: Simple Test Can Help Diagnose Prostate Cancer and Save Your LifeStovsky MD, Bridge, Lake County Council on Aging, 1/1/2011
Lectures
- Prostate Cancer Active Surveillance Optimal Monitoring: DRE, PSA, Re-Biopsy, MRI, Genomics and Proteomics1/1/2016
- Value - Based Reimbursement - Current and Future Strategies1/1/2016
- IsoPSA: Initial Clinical Performance Evaluation of a Novel StructureBased Biomarker for Prostate Cancer in a Multicenter Prospective Trial for Gleason >=71/1/2016
- Join now to see all
Press Mentions
- Business BriefsDecember 18th, 2020
- Cleveland Diagnostics Chief Medical Officer, Mark Stovsky, MD, Participates in Panel Discussion on Early Cancer Detection During Cleveland Clinic's 2019 Medical Innovation SummitOctober 23rd, 2019
- Cleveland Diagnostics Announces FDA Breakthrough Device Designation for Novel Prostate Cancer Diagnostic TestOctober 16th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: